# Rising Pharma Holdings, Inc.: Flurazepam Hydrochloride Capsule shortage reverified (unavailable from this maker)

**Score:** 45/100

| Field | Value |
|---|---|
| Manufacturer | Rising Pharma Holdings, Inc. |
| Drug | Flurazepam Hydrochloride Capsule |
| Dosage form | Capsule |
| Therapeutic category | Neurology, Other |
| Status | Current |
| Stage | Shortage reverified (still listed) |
| Availability | Unavailable |
| Reason | Regulatory delay |
| Presentations affected | 2 |
| Package NDCs | 0378-4430-01, 0378-4415-01 |
| Manufacturer supply note | Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility. |
| First posted | 2022-08-03 |
| Updated | 2026-09-01 |

## Why this score
- Unavailable from this manufacturer.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-05T09:00:14.778Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.